title: Guidelines for the diagnosis, management and prevention of implantable cardiac electronic device infection.
authors.affiliation: Department of Cardiology, Imperial College Healthcare NHS Trust, London, UK.
authors.forename: James L
authors.initials: JL
authors.lastname: Harrison
authors.affiliation: Oxford University Hospitals NHS Trust, Oxford, UK.
authors.forename: Bernard D
authors.initials: BD
authors.lastname: Prendergast
authors.affiliation: Department of Microbiology, University of Leeds and Leeds Teaching Hospital NHS Trust, Leeds, UK.
authors.forename: Jonathan A T
authors.initials: JA
authors.lastname: Sandoe
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D058409:Cardiac Resynchronization Therapy Devices / Q000009:adverse effects; D002309:Cardiology / Q000592:standards*; D017147:Defibrillators, Implantable / Q000009:adverse effects*; D020878:Device Removal / Q000592:standards; D004866:Equipment Contamination / Q000517:prevention & control; D006801:Humans; D017053:Infection Control / Q000379:methods / Q000592:standards; D010138:Pacemaker, Artificial / Q000009:adverse effects*; D017410:Practice Guidelines as Topic; D011237:Predictive Value of Tests; D011474:Prosthesis Design; D016459:Prosthesis-Related Infections / Q000175:diagnosis / Q000453:epidemiology / Q000382:microbiology / Q000517:prevention & control / Q000628:therapy; D012307:Risk Factors; D016896:Treatment Outcome
chemical_list: D000900:Anti-Bacterial Agents